An Intrinsic Calculation For CSPC Pharmaceutical Group Limited (HKG:1093) Suggests It's 47% Undervalued

Simply Wall StNov 5 23:42 ET

CSPC Pharma (01093.HK) will hold a board of directors meeting on November 15 to approve the performance for the first three quarters.

Granting Investment Network November 5th cspc pharma (01093.HK) announced that the board of directors meeting of the company will be held on November 15, 2024, to approve the unaudited consolidated performance announcement of the company and its subsidiaries for the nine months ended September 30, 2024.

Gelonghui FinanceNov 5 05:04 ET

CSPC PHARMA: DATE OF BOARD MEETING

HKEXNov 5 05:02 ET · Announcements

[Brokerage Focus] Zhongtai International cuts CSPC Pharma (01093) target price by 15%, indicating that its performance in the first three quarters will be lower than market expectations.

Jingu financial news | CICC International issues research reports, stating that CSPC Pharma (01093) has issued a profit warning. Due to the significant decrease in the main business revenue of the pharmaceutical business in the third quarter compared to the second quarter, the net income of shareholders in the first three quarters of the company will decrease by 16% year-on-year to approximately 0.38 billion yuan. The main reasons for the decline in pharmaceutical business revenue are: 1) a widening decline in oncology business revenue in the third quarter; 2) poor performance of core products in the central nervous system and cardiovascular fields. The company's performance in the first three quarters will be below market expectations. The report points out that in the short term, oncology drugs still face challenges, and sales of core products in the central nervous system and cardiovascular fields are difficult to recover quickly. FY24-26E oncology

Jinwu Financial NewsNov 3 21:15 ET

Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)

The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.

Zhitong FinanceNov 3 20:45 ET

Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.

①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.

cls.cnNov 1 08:59 ET